Literature DB >> 11953983

Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.

Pernilla Englund1, Inger Nennesmo, Lars Klareskog, Ingrid E Lundberg.   

Abstract

OBJECTIVE: To address the hypothesis that endothelial cells and/or muscle fibers are primary targets in the disease process by analysis of muscle tissue from patients with polymyositis (PM) and dermatomyositis (DM).
METHODS: We included patients with laboratory signs and clinical symptoms typical of myositis, but without detectable infiltration of clusters of inflammatory cells in their muscle biopsy samples. An immunohistochemical technique was applied to identify CD3, CD68, lymphocyte function-associated antigen 1alpha, CD11b, very late activation antigen 4, endothelium 4, interleukin-1alpha (IL-1alpha), intercellular adhesion molecule 1, vascular cell adhesion molecule 1, IgG, IgM, IgA, and HLA-A/B/C in muscle tissue. Fiber type was defined by ATPase staining.
RESULTS: IL-1alpha expression was detected in endothelial cells of capillaries to a greater extent in patients than in controls, and class I major histocompatibility complex (MHC) expression was significantly increased in muscle fibers. We also observed that class I MHC expression was mainly confined to type II muscle fibers.
CONCLUSION: Our findings imply that defined molecular changes of blood vessels and muscle fibers are both independent of adjacent inflammatory infiltrates and could thus be primary events in the development of myositis. Moreover, both IL-1alpha and class I MHC molecules might be important for the development of clinical symptoms in PM and DM patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953983     DOI: 10.1002/art.10140

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

Review 2.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 3.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

4.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Authors:  C Dorph; P Englund; I Nennesmo; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

Review 5.  Exercise: an important component of treatment in the idiopathic inflammatory myopathies.

Authors:  Helene Alexanderson
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 6.  Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.

Authors:  Andrea Henriques-Pons; Kanneboyina Nagaraju
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

7.  Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.

Authors:  Charles Kwok-chong Li; Paul Knopp; Halima Moncrieffe; Bhanu Singh; Sonia Shah; Kanneboyina Nagaraju; Hemlata Varsani; Bin Gao; Lucy R Wedderburn
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

8.  Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.

Authors:  Stina Salomonsson; Cecilia Grundtman; Shi-Jin Zhang; Johanna T Lanner; Charles Li; Abram Katz; Lucy R Wedderburn; Kanneboyina Nagaraju; Ingrid E Lundberg; Håkan Westerblad
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

9.  The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.

Authors:  Qiu Xu; Qiu-Xiang Li; Fang-Fang Bi; Hui-Qian Duan; Yue-Bei Luo; Huan Yang
Journal:  Clin Rheumatol       Date:  2020-07-15       Impact factor: 2.980

10.  Differential immunohistological features of inflammatory myopathies and dysferlinopathy.

Authors:  Jae-Hwan Choi; Yeong-Eun Park; Sung-Il Kim; Jeong-Il Kim; Chang-Hoon Lee; Kyu-Hyun Park; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.